NewsPublic figure
Hunter Biden Says His Father's Cancer Has Spread Further: What That Phase Involves
Hunter Biden told the BBC his father's prostate cancer has moved into the bones and further, and is painful. Here is what progression, castration-resistant disease, and bone pain care actually involve.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What was said, and by whom
In a BBC interview reported on August 8, 2026, Hunter Biden spoke about his father's health.
"The cancer has spread, metastasized into his bones and further," he said. "It's very painful and it's very debilitating in many respects."
He added: "It's really sad to watch. The only thing that I'd say about my dad, about his health right now, is I wish he would complain more, because it's not good." He also said his father is "still doing his thing" and still keeping speaking engagements.
That is the entire new public record. No medical statement was released alongside it. This page does not guess at scans, treatment decisions, or how much time anyone has. What it does is explain the medicine sitting behind those sentences, because many families hear something very similar and have nowhere to look it up.
Two earlier facts are already public. In May 2025 his office said the diagnosis was a Gleason score of 9, Grade Group 5, with spread to bone, and that the cancer appeared hormone-sensitive. In October 2025 a spokeswoman confirmed he had finished several weeks of radiation at Penn Medicine in Philadelphia, alongside hormone therapy.
The sentence worth stopping on
"I wish he would complain more" is the most useful line in the interview, and it has nothing to do with politics.
Not wanting to complain is extremely common. The National Cancer Institute (NCI) treats it as a medical problem rather than a personality trait. Its patient page on cancer pain says plainly: "Pain is not something that you have to 'put up with.'" It also warns that trying to "deal with" pain can make it harder to control later on.
The same page says not to wait until pain is bad before taking pain medicine. Waiting can mean the pain takes longer to settle, or that a larger dose is needed to settle it.
So reporting pain early is not weakness. It is what makes the medicine work.
NCI suggests describing pain in specifics: where it is, what it feels like, whether it is constant or comes and goes, a score from 1 to 10, what makes it better or worse, and whether it interferes with sleeping or eating. Writing this down between visits beats trying to remember it in the room.
What "spread further" tends to mean here
The disease was already in bone when it was announced. So "further" describes progression, not a new diagnosis.
Progression can show up in several ways: new spots on a scan, growth in spots already known, a rising PSA, or new symptoms such as bone pain. Teams usually want more than one of these before changing a plan.
One trap is worth knowing. Hormone therapy lowers PSA whether or not the tumor is truly responding, so NCI says clinicians cannot rely on PSA alone to judge how hormone treatment is going. Scans and symptoms count too.
When hormone treatment stops holding
Advanced prostate cancer usually responds to lowering testosterone, then eventually stops responding. Doctors call that castration-resistant disease. In the trials NCI summarizes, men entered with disease that was progressing while their serum testosterone sat below 50 ng/dL.
This is a phase, not a stopping point. Several treatments are approved specifically for it, and the hormone-blocking usually continues underneath them.
What exists at this stage
Every figure below is a median from one trial with its own entry rules. None of it predicts one person's course.
Androgen-pathway drugs. Abiraterone and enzalutamide both work on hormone signaling by a different route than standard hormone therapy.
Chemotherapy. Docetaxel is the usual first choice. In 755 men whose disease progressed after docetaxel, cabazitaxel gave a median overall survival of 15.1 months versus 12.7 months with mitoxantrone.
Radium-223. Given by vein, it settles in newly forming bone. In 921 men with symptomatic castration-resistant disease in bone and no known spread to organs, median survival was 14.9 months versus 11.3 months on placebo, with fewer symptomatic skeletal events (33% versus 38%) and less spinal cord compression (4% versus 7%).
Lutetium-177 PSMA-617. This requires a PSMA-positive lesion on a PET scan. In the VISION trial, median survival was 15.3 months versus 11.3 months with standard care alone, and median time to a first symptomatic skeletal event or death was 11.5 months versus 6.8 months. The common side effects were fatigue, dry mouth, and nausea.
Olaparib. This one depends on genetics. Among 245 men with changes in BRCA1, BRCA2, or ATM, median survival was 19.1 months versus 14.7 months on the comparison regimen. Nobody knows whether it applies without tumor gene testing, which is worth asking about by name.
Keeping the skeleton intact
Bone-modifying drugs are a separate job from treating the cancer. In men with hormone-resistant prostate cancer and at least one bone metastasis, median time to a first skeletal event was 20.7 months with denosumab and 17.1 months with zoledronic acid. Neither changed survival. Osteonecrosis of the jaw occurred in 2% and 1% respectively, which is why a dental check usually comes first.
Radiation aimed at one painful spot is also standard, and it can sometimes be delivered in a single visit. That matters when travelling to appointments is itself exhausting.
Reasons to go to an emergency department tonight
Anyone with prostate cancer in the bones should know these:
- Back or neck pain together with new weakness, numbness, or tingling in the legs
- Losing control of the bladder or bowels, or numbness around the groin and inner thighs
- Being completely unable to pass urine
The first two can mean the spinal cord is being squeezed. Say it out loud at triage: "I have prostate cancer in my bones and I am worried about spinal cord compression." Treatment within hours can preserve walking.
Call the team the same day for sudden severe bone pain after a small movement, which can mean a fracture. Also call for confusion, heavy thirst, constipation, and nausea together, which can mean high blood calcium.
What this does not mean
A family member's description is not a medical bulletin. "Spread further" is a plain-English phrase, not a stage, and it tells us nothing about scans or scores.
Nothing here says how long anyone has. SEER, NCI's cancer surveillance program, puts five-year relative survival at 40.1% for prostate cancer found after it has spread to distant sites, which is about 9% of cases. Across all stages the figure is 98.2%. Both come from men diagnosed between 2016 and 2022, and both are group averages from men treated under older standards.
"Debilitating" describes how someone is doing, not where the disease is going. And a public figure's course says nothing about anyone else's.
Sources
- https://www.cancer.gov/about-cancer/treatment/side-effects/pain
- https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq
- https://seer.cancer.gov/statfacts/html/prost.html
- https://www.foxnews.com/politics/joe-biden-cancer-spread-further-leaving-very-painful-condition-hunter-reveals
- https://www.bostonglobe.com/2026/08/08/world/joe-biden-cancer-spread-hunter-biden/
- https://www.cbsnews.com/news/biden-completes-round-of-radiation-therapy-aggressive-prostate-cancer/
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Prostate cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.